Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04858334
Title A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

pancreatic squamous cell carcinoma

pancreatic adenosquamous carcinoma

pancreatic cancer

pancreatic acinar cell adenocarcinoma

Therapies

Olaparib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST